This unique, patented implant was released by
the US Food and Drug Administration (FDA) in 1989.
The drawings above
show an implant after surgery
and six months later after tissue has grown into the implant.
Today, over 30,000 people worldwide have
benefited from this natural alternative, which is now known as the Bio-eye (tm)
hydroxyapatite ocular implant. In addition to natural eye movement, the Bio-eye
ocular implant offers many less-obvious benefits. It reduces implant migration
and extrusion, which were common with the first implants.
It can prevent drooping of the lower lid by
lending support to the artificial eye via a peg connection. These are important
benefits that can eliminate the need to choose between further corrective
surgery and an unsatisfactory appearance.
The benefits of natural movement and fewer
long-term problems have made the Bio-eye ocular implant the implant of choice
among leading oculoplastic surgeons worldwide.
